Chlorcyclizine - CAS 82-93-9
Catalog number: 82-93-9
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C18H21ClN2
Molecular Weight:
300.83
COA:
Inquire
Targets:
Histamine Receptor
Description:
Chlorcyclizine is a first-generation Histamine Receptor antagonist of the phenylpiperazine class. It can be used primarily to treat allergy symptoms such as rhinitis, urticaria, and pruritus, and may also be used as an antiemetic. Chlorcyclizine also has some anticholinergic, antiserotonergic, and local anesthetic properties. It also has been studied as a potential treatment for hepatitis C.
Publictions citing BOC Sciences Products
  • >> More
Purity:
98%
Appearance:
yellow to orange oil
Synonyms:
1-[(4-Chlorophenyl)(phenyl)methyl]-4-methylpiperazine, 1-[(4-Chlorophenyl)phenylmethyl]-4-methyl-piperazine; 1620-21-9 (HCl salt); Di-Paralene; Mantadil; Pruresidine; Trihistan;
Solubility:
Soluble in DMSO
Storage:
-20℃ Freezer
MSDS:
Inquire
Application:
allergy symptoms
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Milligrams-Grams
InChIKey:
WFNAKBGANONZEQ-UHFFFAOYSA-N
InChI:
InChI=1S/C18H21ClN2/c1-20-11-13-21(14-12-20)18(15-5-3-2-4-6-15)16-7-9-17(19)10-8-16/h2-10,18H,11-14H2,1H3
Canonical SMILES:
CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
1.Enantiomeric quality control of antihistamines in pharmaceuticals by affinity electrokinetic chromatography with human serum albumin as chiral selector.
Martínez-Gómez MA1, Sagrado S, Villanueva-Camañas RM, Medina-Hernández MJ. Anal Chim Acta. 2007 Jun 5;592(2):202-9. Epub 2007 Apr 21.
The present paper deals with the enantiomeric separation of six antihistaminic enantiomers by affinity electrokinetic chromatography (AEKC)-partial filling technique using human serum albumin (HSA) as chiral selector. A multivariate optimization approach of the most critical experimental variables in enantioresolution, running pH, HSA concentration and HSA plug length (SPL) was carried out since there are interactions between variables that could not be considered in an univariate optimization. The estimated and experimental resolution values obtained for antihistaminic enantiomers varied from 1.13 (for orphenadrine) to 2.15 (for brompheniramine). The optimum experimental conditions for enantioresolution of each compound were: brompheniramine, pH 8.5, [HSA] 180 microM, SPL 180 s; chlorcyclizine, pH 6.5, [HSA] 180 microM, SPL 150 s; chlorpheniramine, pH 8.25, [HSA] 160 microM, SPL 150 s; hydroxyzine, pH 7.0, [HSA] 180 microM, SPL 150 s; and orphenadrine, pH 7.
2.Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.
He S1, Xiao J2, Dulcey AE2, Lin B1, Rolt A2, Hu Z1, Hu X2, Wang AQ2, Xu X2, Southall N2, Ferrer M2, Zheng W2, Liang TJ1, Marugan JJ2. J Med Chem. 2016 Feb 11;59(3):841-53. doi: 10.1021/acs.jmedchem.5b00752. Epub 2016 Feb 1.
Recently, we reported that chlorcyclizine (CCZ, Rac-2), an over-the-counter antihistamine piperazine drug, possesses in vitro and in vivo activity against hepatitis C virus. Here, we describe structure-activity relationship (SAR) efforts that resulted in the optimization of novel chlorcyclizine derivatives as anti-HCV agents. Several compounds exhibited EC50 values below 10 nM against HCV infection, cytotoxicity selectivity indices above 2000, and showed improved in vivo pharmacokinetic properties. The optimized molecules can serve as lead preclinical candidates for the treatment of hepatitis C virus infection and as probes to study hepatitis C virus pathogenesis and host-virus interaction.
3.Pronounced inhibitory effect of chlorcyclizine (CCZ) in experimental hepatocarcinoma.
Dastidar SG1, Ganguly K, Mahapatra SK, Dutta NK, Mazumdar K, Chakrabarty AN, Motohashi N. In Vivo. 2006 Jan-Feb;20(1):97-102.
Thepiperazine chlorcyclizine HCl (CCZ), possessing significant antimetabolic as well as virucidal and virustatic activities against the human immunodeficiency virus (HIV) and other retroviruses, was selected to determine its anticarcinogenic potential The anticancer activity of CCZ was evaluated against procarcinogen n-diethylnitrosamine (NDA)-initiated hepatocarcinogenesis, which was subsequently promoted by phenobarbital (PB) in male Sprague-Dawley rats. The anticancer efficacy of CCZ was monitored by estimating some potential markers of neoplastic and preneoplastic hepatic conditions, e.g., glutathione (GSH), glutathione-S-transferase (GST) and gamma-glutamyl transpeptidase (gammaGTP). CCZ exhibited antineoplastic activity on a long-term therapeutic basis. Furthermore, this drug restricted the exponential increase of the antioxidant markers in the hyperplastic nodule and the surrounding liver tissues in comparison with the carcinogen-controlled rats during the entire period of treatment.
4.Effects of the histamine H1 antagonist chlorcyclizine on rat fetal palate development.
Enright BP1, Gu YZ, Snyder RD, Dugyala RR, Obert LA, Treinen KA, McIntyre BS, Veneziale RW. Birth Defects Res B Dev Reprod Toxicol. 2010 Dec;89(6):474-84. doi: 10.1002/bdrb.20261.
BACKGROUND: The effects of histamine H1 antagonist chlorcyclizine on rat palate development were characterized following in utero exposure.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Histamine Receptor Products


CAS 1620-21-9 Chlorcyclizine hydrochloride

Chlorcyclizine hydrochloride
(CAS: 1620-21-9)

The hydrochloride salt form of Chlorcyclizine which could be used as an antihistamine agent and is also found to have anticholinergic effect at some extent.

CAS 3964-81-6 Azatadine

Azatadine
(CAS: 3964-81-6)

Azatadine is a new antihistamine acts as histamine for histamine H1- receptor inhibitor ( IC50 = 6.5 nM and 10 nM, respectively).

CAS 73903-17-0 JNJ-10191584

JNJ-10191584
(CAS: 73903-17-0)

JNJ-10191584 is a selective histamine H4 receptor antagonist. It inhibits mast cell in vitro with IC50 value of 138nM. JNJ-10191584 has antiinflammatory and ana...

CAS 100299-08-9 Pemirolast potassium

Pemirolast potassium
(CAS: 100299-08-9)

Pemirolast potassium (BMY 26517) is a histamine H1 antagonist and mast cell stabilizer that acts as an antiallergic agent.

ABT-239
(CAS: 460746-46-7)

ABT-239 is a novel, highly efficacious, non-imidazole class of H3R antagonist has been investigated as a treatment for ADHD, Alzheimer's disease, and schizophr...

Mizolastine dihydrochloride
(CAS: 1056596-82-7)

The dihydrochloride salt form of Mizolastine which is effective in the treatment of seasonal allergic rhinitis, perennial allergic rhinitis and other allergy sy...

CAS 87848-99-5 Acrivastine

Acrivastine
(CAS: 87848-99-5)

Acrivastine, also known as BW825C, is an antihistamine with peripheral H1-antagonist potency equal to that of triprolidine for the treatment of allergic rhiniti...

CAS 3978-86-7 Azatadine dimaleate

Azatadine dimaleate
(CAS: 3978-86-7)

Azatadine is an histamine and cholinergic inhibitor with IC50 of 6.5 nM and 10 nM, respectively.

CAS 132-20-7 Pheniramine Maleate

Pheniramine Maleate
(CAS: 132-20-7)

Pheniramine Maleate is an antihistamine with anticholinergic properties used to treat allergic conditions such as hay fever or urticaria.

CAS 147-20-6 Diphenylpyraline

Diphenylpyraline
(CAS: 147-20-6)

Diphenylpyraline, a piperidine derivative, has been found to be a H1 receptor antagonist that could be probably effective against some allergy acts.

CAS 140462-76-6 Olopatadine HCl

Olopatadine HCl
(CAS: 140462-76-6)

Olopatadine HCl is a histamine blocker and mast cell stabilizer with an IC50 of 559 μM for the release of histamine

OUP16
(CAS: 1038917-11-1)

OUP16 is a potent and selective histamine H4 receptor(hH4R) agonist with 40-fold selectivity over the hH3R and superior to its (2S,5S)-configured optical antipo...

CAS 85604-00-8 Zaltidine

Zaltidine
(CAS: 85604-00-8)

Zaltidine is an effective but hepatotoxic H2-receptor antagonist. It has higher incidence of hepatic damage than with commonly used H2-receptor antagonists. It ...

CAS 66357-59-3 Ranitidine

Ranitidine
(CAS: 66357-59-3)

Ranitidine is a histamine H2-receptor antagonist that inhibits stomach acid production. It is commonly used in treatment of peptic ulcer disease and gastroesoph...

CAS 190786-44-8 Bepotastine Besilate

Bepotastine Besilate
(CAS: 190786-44-8)

Bepotastine stimulates P-gp-mediated ATP hydrolysis with Km, Vmax, and Vmax/Km values of 1.25 mM, 108 nmol/min/mg protein, and 0.087 mL/min/mg protein, respecti...

Pitolisant oxalate
(CAS: 362665-57-4)

Tiprolisant is potent and selective nonimidazole inverse agonist at the histamine H3 receptor. (Ki=0.16 nM).

CAS 6138-79-0 Triprolidine hydrochloride

Triprolidine hydrochloride
(CAS: 6138-79-0)

Triprolidine hydrochloride is a potent H1 histamine receptor antagonist. It is used in allergic rhinitis, urticaria and asthma. It is an over-the-counter antihi...

CAS 82-93-9 Chlorcyclizine

Chlorcyclizine
(CAS: 82-93-9)

Chlorcyclizine is a first-generation Histamine Receptor antagonist of the phenylpiperazine class. It can be used primarily to treat allergy symptoms such as rhi...

CAS 118288-08-7 Lafutidine

Lafutidine
(CAS: 118288-08-7)

Lafutidine, a newly developed histamine H(2)-receptor antagonist, inhibits gastric acid secretion.

CAS 6153-33-9 Mebhydroline Napadisylate

Mebhydroline Napadisylate
(CAS: 6153-33-9)

Mebhydroline Napadisylate is an antihistamine used for symptomatic relief of allergic symptoms caused by histamine release, including nasal allergies and allerg...

Chemical Structure

CAS 82-93-9 Chlorcyclizine

Quick Inquiry

Verification code

Featured Items